Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation

Second allogeneic hematopoietic stem cell transplantation (allo-HSCT) has a low survival outcome and a high non-relapse mortality (NRM) rate which is a major obstacle to this treatment. We hypothesized that the status of malnourishment after first allo-HSCT as represented by the geriatric nutritiona...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of hematology 2020-07, Vol.99 (7), p.1655-1665
Hauptverfasser: Kaito, Satoshi, Wada, Atsushi, Adachi, Hiroto, Konuma, Ryosuke, Kishida, Yuya, Nagata, Akihito, Konishi, Tatsuya, Yamada, Yuta, Kumagai, Takuma, Yoshifuji, Kota, Mukae, Junichi, Akiyama, Megumi, Inamoto, Kyoko, Toya, Takashi, Igarashi, Aiko, Najima, Yuho, Muto, Hideharu, Kobayashi, Takeshi, Kakihana, Kazuhiko, Ohashi, Kazuteru, Sakamaki, Hisashi, Doki, Noriko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Second allogeneic hematopoietic stem cell transplantation (allo-HSCT) has a low survival outcome and a high non-relapse mortality (NRM) rate which is a major obstacle to this treatment. We hypothesized that the status of malnourishment after first allo-HSCT as represented by the geriatric nutritional risk index (GNRI) could be used as a prognostic factor to determine the outcomes of second allo-HSCT. A total of 108 patients with a median age of 42 (range, 17–69) years, who received second allo-HSCT for disease recurrence after first allo-HSCT from our institution, were included in this study. Low GNRI had a significant impact on NRM at 2 years after second allo-HSCT: 56.9% in patients with GNRI ≤ 92 compared with 27.5% in patients with GNRI > 92 ( P  = 0.002). In multivariate analysis, GNRI of ≤ 92 was the only significant factor for NRM (hazard ratio [HR] 2.29, 95% confidence interval [CI] 1.15–4.56, P  = 0.018). High-risk disease status at second allo-HSCT (HR 2.74, 95% CI 1.46–5.14, P  = 0.002) and GNRI of ≤ 92 (HR 1.70, 95% CI 1.02–2.82, P  = 0.042) were identified as significant factors for overall survival (OS). A score of 1 was assigned to each factor, and the OS rate at 2 years after second allo-HSCT decreased according to the score: 53.0% in patients with score 0, 32.3% with score 1, and 2.5% with score 2 ( P  
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-020-04089-0